FibroBiologics enters $1.02M secured debt purchase agreement
FibroBiologics digitally signed a securities purchase agreement with Peak One Opportunity Fund on Oct 7, 2026, to sell a $1M convertible debenture. This secondary offering of approximately 89% of the debt's face value is potentially dilutive.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed